Research location
Wiesbaden
Hesse, Germany
Advertisement
Research activity in Wiesbaden
Hesse, GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 56 trials and 62 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Wiesbaden
56 linked trials · page 1 of 2A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)NCT07361510 · 2026-03-12 · 1 site observation
RECRUITING
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of RecurrenceNCT06830720 · 2025-02-20 · 2 site observations
RECRUITING
Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast CancerNCT06201234 · 2024-12-13 · 1 site observation
RECRUITING
PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFSNCT05792150 · 2022-12-07 · 1 site observation
RECRUITING
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)NCT06018337 · 2024-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive DisorderNCT05593029 · 2022-11-09 · 1 site observation
COMPLETED
Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002)NCT04725188 · 2021-04-20 · 1 site observation
COMPLETED
Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)NCT04577404 · 2020-10-29 · 1 site observation
COMPLETED
Sacituzumab Govitecan in Primary HER2-negative Breast CancerNCT04595565 · 2020-10-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBCNCT04565054 · 2020-09-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Real-life Pan-HER-blockade With NeratinibNCT04388384 · 2020-07-02 · 1 site observation
COMPLETED
Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBCNCT04055493 · 2019-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)NCT03797326 · 2019-02-12 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)NCT03725059 · 2018-12-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment DecisionsNCT03465332 · 2018-04-19 · 1 site observation
COMPLETED
Effects of Music or Hypnotherapy on Cancer Patients During ChemotherapyNCT03740984 · 2018-02-01 · 1 site observation
TERMINATED
Effect of the GSK2245035 on the Allergen-induced Asthmatic ResponseNCT02833974 · 2016-12-05 · 1 site observation
COMPLETED
Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT02570165 · 2015-11-06 · 1 site observation
COMPLETED
European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)NCT02495974 · 2015-09-08 · 1 site observation
COMPLETED
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary SurgeryNCT02466737 · 2015-09-01 · 3 site observations
ACTIVE_NOT_RECRUITING
A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02345161 · 2015-01-23 · 1 site observation
COMPLETED
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerNCT02246621 · 2014-11-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary DiseaseNCT02207829 · 2014-09-01 · 1 site observation
COMPLETED
Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation
COMPLETED
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01323634 · 2011-03-18 · 1 site observation
COMPLETED
An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study ANCT01328444 · 2011-03-01 · 1 site observation
COMPLETED
Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.NCT03105765 · 2011-01-01 · 1 site observation
COMPLETED
28-day Repeat Dose Study of GSK573719NCT01030965 · 2009-12-15 · 1 site observation
COMPLETED
SCOT Registry: Small Cell Lung Cancer Treatment and OutcomeNCT00997061 · 2009-11-01 · 1 site observation
COMPLETED
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01017952 · 2009-09-25 · 1 site observation
COMPLETED
GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary DiseaseNCT00950807 · 2009-09-01 · 1 site observation
COMPLETED
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerNCT00820222 · 2009-04-14 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild AsthmaticsNCT00857857 · 2009-02-16 · 1 site observation
COMPLETED
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung CancerNCT00707304 · 2008-11-01 · 1 site observation
COMPLETED
Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.NCT00770640 · 2008-08-01 · 1 site observation
COMPLETED
Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.NCT00770445 · 2008-05-01 · 1 site observation
COMPLETED
Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.NCT00775840 · 2008-01-01 · 1 site observation
COMPLETED
Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.NCT00600171 · 2007-12-01 · 1 site observation
COMPLETED
Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IVNCT00527826 · 2007-11-01 · 1 site observation
COMPLETED
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.NCT00519376 · 2007-08-01 · 1 site observation
COMPLETED
Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00422604 · 2006-10-01 · 1 site observation
COMPLETED
Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure InfectionNCT00402727 · 2006-09-01 · 1 site observation
COMPLETED
Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.NCT00771004 · 2006-08-01 · 1 site observation
COMPLETED
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNCT00338247 · 2006-07-01 · 1 site observation
APPROVED_FOR_MARKETING
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung CancerNCT00359359 · 2006-07-01 · 1 site observation
COMPLETED
Repeat Doses Of A New Medication (GW642444) In Asthmatic PatientsNCT00347139 · 2006-05-23 · 1 site observation
COMPLETED
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic PatientsNCT00358488 · 2006-04-01 · 1 site observation
COMPLETED
COX-2 Inhibitor Study In Patients With Rheumatoid ArthritisNCT00113308 · 2005-06-01 · 1 site observation
COMPLETED
Investigation Of A New Medication (GW642444) In Asthmatic PatientsNCT00354874 · 2005-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.